Last reviewed · How we verify

Botulinum Toxin Type A in saline water

Helse Nord-Trøndelag HF · Phase 3 active Small molecule

Botulinum Toxin Type A in saline water is a Neurotoxin; Acetylcholine release inhibitor Small molecule drug developed by Helse Nord-Trøndelag HF. It is currently in Phase 3 development for Cervical dystonia, Blepharospasm, Hemifacial spasm. Also known as: Botox.

Botulinum toxin type A blocks acetylcholine release at the neuromuscular junction by cleaving SNARE proteins, causing temporary muscle paralysis.

Botulinum toxin type A blocks acetylcholine release at the neuromuscular junction by cleaving SNARE proteins, causing temporary muscle paralysis. Used for Cervical dystonia, Blepharospasm, Hemifacial spasm.

At a glance

Generic nameBotulinum Toxin Type A in saline water
Also known asBotox
SponsorHelse Nord-Trøndelag HF
Drug classNeurotoxin; Acetylcholine release inhibitor
TargetSNAP-25 (synaptosome-associated protein of 25 kDa)
ModalitySmall molecule
Therapeutic areaNeurology; Movement Disorders; Aesthetics
PhasePhase 3

Mechanism of action

Botulinum toxin type A is a neurotoxin that irreversibly cleaves SNARE proteins (specifically SNAP-25) required for acetylcholine vesicle fusion and release at the neuromuscular junction. This results in temporary paralysis of injected muscles lasting 3-4 months. The toxin is formulated in saline for clinical administration and is used therapeutically to reduce muscle hyperactivity and associated symptoms in various conditions.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Botulinum Toxin Type A in saline water

What is Botulinum Toxin Type A in saline water?

Botulinum Toxin Type A in saline water is a Neurotoxin; Acetylcholine release inhibitor drug developed by Helse Nord-Trøndelag HF, indicated for Cervical dystonia, Blepharospasm, Hemifacial spasm.

How does Botulinum Toxin Type A in saline water work?

Botulinum toxin type A blocks acetylcholine release at the neuromuscular junction by cleaving SNARE proteins, causing temporary muscle paralysis.

What is Botulinum Toxin Type A in saline water used for?

Botulinum Toxin Type A in saline water is indicated for Cervical dystonia, Blepharospasm, Hemifacial spasm, Spasticity, Chronic migraine.

Who makes Botulinum Toxin Type A in saline water?

Botulinum Toxin Type A in saline water is developed by Helse Nord-Trøndelag HF (see full Helse Nord-Trøndelag HF pipeline at /company/helse-nord-tr-ndelag-hf).

Is Botulinum Toxin Type A in saline water also known as anything else?

Botulinum Toxin Type A in saline water is also known as Botox.

What drug class is Botulinum Toxin Type A in saline water in?

Botulinum Toxin Type A in saline water belongs to the Neurotoxin; Acetylcholine release inhibitor class. See all Neurotoxin; Acetylcholine release inhibitor drugs at /class/neurotoxin-acetylcholine-release-inhibitor.

What development phase is Botulinum Toxin Type A in saline water in?

Botulinum Toxin Type A in saline water is in Phase 3.

What are the side effects of Botulinum Toxin Type A in saline water?

Common side effects of Botulinum Toxin Type A in saline water include Muscle weakness or paralysis in unintended muscles, Headache, Neck pain, Injection site pain or bruising, Flu-like symptoms, Ptosis (drooping eyelid).

What does Botulinum Toxin Type A in saline water target?

Botulinum Toxin Type A in saline water targets SNAP-25 (synaptosome-associated protein of 25 kDa) and is a Neurotoxin; Acetylcholine release inhibitor.

Related